Terray Therapeutics, which specializes in AI-enabled drug discovery, emerges from stealth with a $60M Series A led by Madrona Venture Group (Keerthi Vedantam/dot.LA)

Keerthi Vedantam / dot.LA:Terray Therapeutics, which specializes in AI-enabled drug discovery, emerges from stealth with a $60M Series A led by Madrona Venture Group  —  After three years in stealth mode, a Pasadena biotech startup has emerged with $60 million and, it believes, a new way to create drugs.

Terray Therapeutics, which specializes in AI-enabled drug discovery, emerges from stealth with a $60M Series A led by Madrona Venture Group (Keerthi Vedantam/dot.LA)

Keerthi Vedantam / dot.LA:
Terray Therapeutics, which specializes in AI-enabled drug discovery, emerges from stealth with a $60M Series A led by Madrona Venture Group  —  After three years in stealth mode, a Pasadena biotech startup has emerged with $60 million and, it believes, a new way to create drugs.